LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.14
-0.10 (-1.38%)
Mar 2, 2026, 4:00 PM EST - Market closed
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 7 analysts that cover LifeStance Health Group stock have a consensus rating of "Strong Buy" and an average price target of $9.57, which forecasts a 34.03% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $12.
Price Target: $9.57 (+34.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LifeStance Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 2 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +40.06% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +68.07% | Feb 26, 2026 |
| Keybanc | Keybanc | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +26.05% | Feb 26, 2026 |
| BTIG | BTIG | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +54.06% | Feb 2, 2026 |
| BTIG | BTIG | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +40.06% | Dec 12, 2025 |
Financial Forecast
Revenue This Year
1.66B
from 1.42B
Increased by 16.27%
Revenue Next Year
1.89B
from 1.66B
Increased by 14.13%
EPS This Year
0.04
from 0.02
Increased by 112.52%
EPS Next Year
0.18
from 0.04
Increased by 312.77%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | 2.0B | |
| Avg | 1.7B | 1.9B | |
| Low | 1.6B | 1.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.9% | 19.7% | |
| Avg | 16.3% | 14.1% | |
| Low | 10.0% | 6.6% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.07 | 0.27 |
| Avg | 0.04 | 0.18 |
| Low | -0.01 | 0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 267.5% | 542.3% |
| Avg | 112.5% | 312.8% |
| Low | - | 38.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.